ʻO ka waikawa nukleika Candida Albicans

ʻO nā ʻano Candida ka flora fungal maʻamau nui loa i loko o ke kino o ke kanaka, kahi i loaʻa nui ʻia ma ke ala hanu, ke ala ʻai, ke ala genitourinary a me nā ʻōpū ʻē aʻe e kamaʻilio pū ana me ke ao waho. ʻAʻole ia he pathogenic ma ke ʻano laulā a no nā bacteria pathogenic conditional. Ma muli o ka hoʻohana nui ʻana o nā mea immunosuppressive, ka hoʻomohala ʻana o ka radiotherapy tumor, chemotherapy, invasive treatment, a me ka hoʻoili ʻana o nā ʻōpū, a me ka hoʻohana nui ʻana o ka nui o nā antibiotics ākea, lilo ka flora maʻamau i mea kaulike ʻole, e alakaʻi ana i nā maʻi Candida ma ke ala genitourinary a me ke ala hanu.

Hiki i ka maʻi Candida i loko o ke ala genitourinary ke hoʻoulu i nā wahine e ʻeha i ka candidal vulvitis a me ka vaginitis, a me nā kāne e ʻeha i ka candidal balanitis, acroposthitis a me ka prostatitis, ka mea e hoʻopilikia nui i ke ola a me ka hana a nā maʻi. Ke piʻi nei ka nui o ka hanana o ka candidiasis ala genital i kēlā me kēia makahiki. I waena o lākou, ʻo nā maʻi candida ala genital wahine he 36%, a ʻo nā kāne he 9%, a ʻo nā maʻi Candida albicans (CA) nā mea nui, e helu ana ma kahi o 80%.

ʻO ka maʻi fungal maʻamau o ka maʻi Candida albicans kahi kumu nui o ka make mai nā maʻi nosocomial. Ma waena o nā mea maʻi koʻikoʻi ma ICU, ʻo ka maʻi Candida albicans ma kahi o 40%. Ma waena o nā maʻi fungal visceral āpau, ʻo nā maʻi fungal pulmonary ka hapa nui a ke piʻi nei lākou i kēlā me kēia makahiki. ʻO ka ʻike mua ʻana a me ka ʻike ʻana i nā maʻi fungal pulmonary he mea koʻikoʻi koʻikoʻi.

ʻO nā hōʻike lapaʻau o kēia manawa o nā genotypes Candida albicans e pili ana i ke ʻano A, ke ʻano B, a me ke ʻano C, a ʻo kēlā mau genotypes ʻekolu he 90% ka nui. Hiki i ka ʻike pololei ʻana i ka maʻi Candida albicans ke hāʻawi i nā hōʻike no ka ʻike ʻana a me ka mālama ʻana i ka candidal vulvitis a me ka vaginitis, ka male candidal balanitis, ka acroposthitis a me ka prostatitis, a me ka maʻi Candida albicans ma ke ala hanu.